uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies

por Duffy, Michael J, McGowan, Patricia M, Harbeck, Nadia, Thomssen, Christoph, Schmitt, Manfred
Publicado 2014

The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?

por Duffy, Michael J, Mullooly, Maeve, O'Donovan, Norma, Sukor, Sumainizah, Crown, John, Pierce, Aisling, McGowan, Patricia M
Publicado 2011

ADAM10: a new player in breast cancer progression?

por Mullooly, Maeve, McGowan, Patricia M, Kennedy, Susan A, Madden, Stephen F, Crown, John, O' Donovan, Norma, Duffy, Michael J
Publicado 2015

Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer

por Canonici, Alexandra, Gijsen, Merel, Mullooly, Maeve, Bennett, Ruth, Bouguern, Noujoude, Pedersen, Kasper, O'Brien, Neil A, Roxanis, Ioannis, Li, Ji-Liang, Bridge, Esther, Finn, Richard, Slamon, Dennis, McGowan, Patricia, Duffy, Michael J., O'Donovan, Norma, Crown, John, Kong, Anthony
Publicado 2013

ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis

por Romagnoli, Mathilde, Mineva, Nora D, Polmear, Michael, Conrad, Catharina, Srinivasan, Srimathi, Loussouarn, Delphine, Barillé-Nion, Sophie, Georgakoudi, Irene, Dagg, Áine, McDermott, Enda W, Duffy, Michael J, McGowan, Patricia M, Schlomann, Uwe, Parsons, Maddy, Bartsch, Jörg W, Sonenshein, Gail E
Publicado 2014